The helix-loop-helix containing transcription factor USF binds to and transactivates the promoter of the p53 tumor suppressor gene.

Por Reisman, D, Rotter, V
Publicado em 1993

trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1.

Por Reisman, D, Sugden, B
Publicado em 1986

Induced expression from the Moloney murine leukemia virus long terminal repeat during differentiation of human myeloid cells is mediated through its transcriptional enhancer.

Por Reisman, D, Rotter, V
Publicado em 1989

Expression from the murine p53 promoter is mediated by factor binding to a downstream helix-loop-helix recognition motif.

Por Ronen, D, Rotter, V, Reisman, D
Publicado em 1991

Human p53 oncogene contains one promoter upstream of exon 1 and a second, stronger promoter within intron 1.

Por Reisman, D, Greenberg, M, Rotter, V
Publicado em 1988

A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components.

Por Reisman, D, Yates, J, Sugden, B
Publicado em 1985

Pharmacologic reversal of epigenetic silencing of the anticancer protein BRM: a novel targeted treatment strategy

Por Gramling, S, Rogers, C, Liu, G, Reisman, D
Publicado em 2011

A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells.

Por Yates, J, Warren, N, Reisman, D, Sugden, B
Publicado em 1984

Transactivation of the human p53 tumor suppressor gene by c-Myc/Max contributes to elevated mutant p53 expression in some tumors.

Por Roy, B, Beamon, J, Balint, E, Reisman, D
Publicado em 1994

Cloning overlapping DNA fragments from the B95-8 strain of Epstein-Barr virus reveals a site of homology to the internal repetition.

Por Buell, G N, Reisman, D, Kintner, C, Crouse, G, Sugden, B
Publicado em 1981

Oncogenic targeting of BRM drives malignancy through C/EBPβ-dependent induction of α5 integrin

Por Damiano, L, Stewart, KM, Cohet, N, Mouw, JK, Lakins, JN, Debnath, J, Reisman, D, Nickerson, JA, Imbalzano, AN, Weaver, VM
Publicado em 2013

Two novel BRM insertion promoter sequence variants are associated with loss of BRM expression and lung cancer risk

Por Liu, G, Gramling, S, Munoz, D, Cheng, D, Azad, AK, Mirshams, M, Chen, Z, Xu, W, Roberts, H, Shepherd, FA, Tsao, MS, Reisman, D
Publicado em 2011